Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.87M.
ENTERPRISE VALUE (EV)
$2.87M
Nexalin Technology, Inc.
Market Cap
$3.52M
Enterprise Value (EV)
$2.87M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Nexalin Technology, Inc. (NXL) | $3.52M | $2.87M |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.68M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | $1.04M |
| Moolec Science S.A. (MLEC)vs › | $3.40M | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.85M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.24M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | $21.49M |
Market Cap
$3.52M
Total Debt
$0.00
Cash
$654783.00
Enterprise Value
$2.87M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
